Do you frequently recommend the HPV vaccination series to patients above 26 years old?
What patient factors would make you more likely to recommend? Cost-effectiveness discussion as published in Annals of Internal Medicine: Laprise et al., PMID 39586101
1 Answer
Mednet MemberInvited Expert
Primary Care · Montefiore Wakefield Ambulatory Care Center
Answered on
The FDA approved the use of the 9-valent HPV vaccine in adults aged 27-45 in October 2018. In June 2019, the ACIP recommended that men and women aged 27-45 discuss vaccination with their doctor in a shared decision-making model. Extending mass vaccination for all adults aged 27-45 would cost approxi...
Join for free or sign in to see the full answer